Baby Pibu™ proudly announces that three of its products, Pibu’s™ Bathtime Wash, Pibu’s™ Baby Butter and Hydrating Ointment, have earned the National Eczema Association’s Seal of Acceptance. Having only been in the marketplace for one month, this is huge accomplishment for the Baby Pibu™ team and an accolade that we proudly accept. More importantly, this gives you, our consumers – parents trying to make informed, healthy decisions – additional education and clarity when deciding on the best products for your baby.
Per the National Eczema Association (NEA) website: ‘The NEA Seal of Acceptance™ helps individuals recognize products that are suitable for care of eczema or sensitive-skin. The presence of the NEA Seal of Acceptance™ logo will empower consumers to make informed purchase decisions to help manage eczema and sensitive-skin.’
Obtaining this seal of approval is very difficult and involves several different levels of examination. The NEA has stringent requirements including clinical testing, but they also have a panel of dermatologists specializing in eczema who help determine if a product is appropriate for eczema individuals.
At Baby Pibu™ we test and select only the safest ingredient for our products. Each and every ingredient has been through extensive scrutiny by panels of board-certified dermatologists. We are proud that the NEA deems Pibu’s™ Bathtime Wash, Pibu’s™ Baby Butter and Hydrating Ointment worthy of their seal of acceptance for consumers with eczema.
Understanding the various tests and terms can be hard, and while consumers can read the details, it’s had to know what they mean. When choosing the best products for eczema-prone or sensitive skin it is important to always look for products that have been clinically tested and thoroughly reviewed by the professionals.
What does it mean to be clinically tested?
Personal care or cosmetic products that claim to be clinically tested have gone through the rigor of further scrutiny through clinical testing at regulated research laboratories in the USA. These laboratories have a panel of investigators including board-certified dermatologists. Tests that are performed include patch testing, cumulative irritation testing, and phototoxicity testing. All of these tests follow a standard protocol approved by the Institutional Review Board (IRB).
Patch testing is a test that follows a product over six weeks to determine whether or not it is causing any allergic reactions. Baby Pibu™ products were put through this testing and were found to be non-sensitizing (non-allergenic) and non-irritating.
Cumulative irritation testing is a test that runs for a two week time period. In this test, products are examined to see if they cause cumulative dermal (skin) irritation or not. Baby Pibu™ products were found to cause no significant cumulative dermal irritation.
Phototoxicity testing is a test that determines whether or not a product induces a phototoxic response, meaning the product could facilitate sunburn when someone spends time in the sun. Baby Pibu™ products were not found to cause a dermal phototoxic response.
Baby Pibu™ products underwent patch, cumulative irritation and photoxicity testing and were found non-irritating, non-sensitizing and had no phototoxic response. This is great news for our tiny customers with sensitive, eczema-prone skin.
At Baby Pibu™, we understand that you’ve put your trust in our company, and we hold that in high regard. You have our commitment to continually provide the high-caliber products and education that you and your baby deserve. For more information on the National Eczema Association and its Seal of Acceptance, visit the NEA website at www.nationaleczema.org.